DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Response to Amendment
As of the reply filed 9/25/2026, claims 1-2, 4-11, 17, 19-20, and 23 are pending. Claims 1, 4-5, 8, 17, and 19-20 have been amended. Claims 3, 12-16, 18, 21-22 and 24-32 are cancelled.
Response to Arguments
Applicant’s amendments to claim 4 have not overcome the previously filed objections, therefore claim 4 remains objected to.
The previously filed drawing objections were partially addressed by the Specification filed 9/25/2026, which added reference characters 75, 76, 78, 87, and 88. However, the requirement for new drawings due to the hand-drawn and difficult-to-read nature of the drawings filed 2/03/2025 was not addressed by the Remarks filed 9/25/2026. Therefore, the drawings remain objected to.
Applicant’s arguments regarding claim 1 are persuasive, therefore this rejection is withdrawn.
Applicant’s arguments regarding claim 8 (see page 10 of Remarks) have been considered but they are not persuasive. Applicant argues that “the alleged concave section of Yaari extends through the entire width since it is formed by the curvature of the arms. Thus it is not spaced from the edges as in claim 8”, but the Examiner argues that the present claim language does not require that the entirety of the concave section be discretely formed within the bounds of the edges as argued, but that the folded concavities seen in Figs. 13-14 read on the amended language. A portion of the folded concavities is spaced between the edges as claimed, therefore these concave sections read on the amended claim language.
The Yaari reference further reads on claim 5, as the folded concavities are formed inward of the first and second arms (see Figs. 13-14, as 60 extends between 20 and 40, the folded concave sections are formed inward of the arms as well). Claim 19 is rejected under 35 U.S.C. 112(a) for containing new matter as the claim language is not supported by the present disclosure.
Applicant’s arguments regarding 17 are moot, as the new rejection relies upon a new secondary reference to teach the amended claim language.
As a terminal disclaimer has not been filed, double patenting rejections still apply.
Claim Objections
Claim 4 is objected to because of the following informalities:
Claim 4, line 2: “one of more of the first arm” contains a spelling error and should be amended to recite “one or more of the first arm” instead.
Claim 4, line 3: “, second arm, or engagement member” is missing articles and should be amended to recite “, the second arm, or the engagement member” instead.
Appropriate correction is required.
Drawings
New corrected drawings in compliance with 37 CFR 1.121(d) are required in this application because the reference characters are hand-written and difficult to read. Additionally, the drawings contain hand-drawn elements which are difficult to examine. Applicant is advised to employ the services of a competent patent draftsperson outside the Office, as the U.S. Patent and Trademark Office no longer prepares new drawings. The corrected drawings are required in reply to the Office action to avoid abandonment of the application. The requirement for corrected drawings will not be held in abeyance.
Corrected drawing sheets in compliance with 37 CFR 1.121(d), or amendment to the specification to add the reference character(s) in the description in compliance with 37 CFR 1.121(b) are required in reply to the Office action to avoid abandonment of the application. Any amended replacement drawing sheet should include all of the figures appearing on the immediate prior version of the sheet, even if only one figure is being amended. Each drawing sheet submitted after the filing date of an application must be labeled in the top margin as either “Replacement Sheet” or “New Sheet” pursuant to 37 CFR 1.121(d). If the changes are not accepted by the examiner, the applicant will be notified and informed of any required corrective action in the next Office action. The objection to the drawings will not be held in abeyance.
Claim Rejections - 35 USC § 112
The following is a quotation of the first paragraph of 35 U.S.C. 112(a):
(a) IN GENERAL.—The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor or joint inventor of carrying out the invention.
The following is a quotation of the first paragraph of pre-AIA 35 U.S.C. 112:
The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor of carrying out his invention.
Claim 19 is rejected under 35 U.S.C. 112(a) or 35 U.S.C. 112 (pre-AIA ), first paragraph, as failing to comply with the written description requirement. The claim(s) contains subject matter which was not described in the specification in such a way as to reasonably convey to one skilled in the relevant art that the inventor or a joint inventor, or for applications subject to pre-AIA 35 U.S.C. 112, the inventor(s), at the time the application was filed, had possession of the claimed invention.
The limitation “wherein the concave section is independent of a position of the first and second arms” lacks support in the present disclosure. The Specification does not include this language and the drawings do not provide adequate support, as the concave section(s) (see 102 in Fig. 3A and 112, 114 in Fig. 3B) cannot be said to be independent of a position of the first and second arms since its position in space is determined by the positioning of the first and second arms. Since they are connected components, the concave section(s) described in the present disclosure cannot be independent of positions of the first and second arms.
The following is a quotation of 35 U.S.C. 112(b):
(b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention.
The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph:
The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention.
Claims 8-11, 5, and 19 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention.
Claim 8 now recites the limitation "the engagement member" in the second to last line. There is insufficient antecedent basis for this limitation in the claim, as previously the claim only mentions “the engagement section” instead. It is recommended that all instances of “engagement member” be replaced with “engagement section” instead.
Please note that all claims that depend from claim 8 inherit this deficiency. Claims, 9-11 and 5 should also be amended as they recite “the engagement member”.
Claim Rejections - 35 USC § 102
In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status.
The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action:
A person shall be entitled to a patent unless –
(a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention.
(a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention.
Claims 8-11, 5, and 19 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Yaari (US PGPub 2014/0163578 A1).
With respect to claim 8, Yaari discloses a medical device (10 in Fig. 1) for treating shoulder dystocia (abstract: “A surgical device for treating shoulder dystocia”) comprising:
a first arm (20) having a proximal portion (portion near 23) and a distal portion (portion near 32), the first arm (20) having a first curved surface (26);
a second arm (40) having a proximal portion (portion near 23) and a distal portion (portion near 52), the second arm (40) having a second curved surface (46);
a shoulder engagement section (60) positioned at least between the distal portion of the first and second arms (PP [0054]: “an engagement member 60 spanning the two arms 20, 40”) and connecting the first and second arms (20 and 40 are connected via 60, see Fig. 1), the engagement section (60) having an upper surface (66) and a lower surface (68 in Fig. 3A), the lower surface (68) having an atraumatic surface and configured to contact and press down on a baby (PP [0061]: “A portion of the lower (bottom) surface 68 (see FIG. 3A) (or the entire lower surface) can be textured or have some small atraumatic projections or other non-smooth surface to provide a good grip on the fetal shoulder for maneuverability”) to reposition the baby upon manipulation of the first and second arms (PP [0059]: “to apply a sufficient force against the baby's shoulder when a downward force is applied by manipulation of the arms 20, 40”), the upper surface (6) having a proximal edge, a distal edge, a first side edge extending between the proximal edge and the distal edge and a second side edge opposite the first side edge and extending between the proximal edge and the distal edge (see upper, left/right, and bottom edges of 60 in Fig. 1), the upper surface (66) having a concave section forming a depression (see folds in Figs. 13-14 forming a plurality of concave depressions) to accommodate the shoulder of the baby (see Figs. 13-16, this concave section accommodates the shoulder of the baby), the concave section positioned in a central region of the engagement member (60) spaced from the distal edge, proximal edge, first side edge and second side edge (the folds in Figs. 13-14 have central portions which are spaced from the exterior edges of the engagement member 60).
Regarding claim 9, Yaari further discloses wherein the concave section (see depressions formed by folds in Figs. 13-14) is formed in a central region of the engagement member (the folds in Figs. 13-14 have central portions which are spaced from the exterior edges of the engagement member 60).
Regarding claim 10, Yaari further discloses a second concave section (see plurality of folds in Figs. 13-14) positioned in the upper surface of the engagement member (60).
Regarding claim 11, Yaari further discloses a concave section (see plurality of folds in Figs. 13-14) on the lower surface (68 in Fig. 3A, see unmarked underside of 60 in Figs. 13-14, the folds also create concave sections on the lower surface) of the engagement member (60).
Regarding claim 5, Yaari further discloses wherein the concave section (see plurality of folds in Figs. 13-14) is formed in the engagement member (60) and formed in a region inward of the first and second arms (20 and 40, the folds extend between 20 and 40 and are formed inward of them).
Regarding claim 19, Yaari further discloses wherein the concave section (see plurality of folds in Figs. 13-14) is independent of a position of the first and second arms (20 and 40, the folds on 60 are not located on the first and second arms 20 and 40 and are independent of their position, relying only on the position of engagement section 60).
Claim Rejections - 35 USC § 103
In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status.
The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action:
A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made.
The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows:
1. Determining the scope and contents of the prior art.
2. Ascertaining the differences between the prior art and the claims at issue.
3. Resolving the level of ordinary skill in the pertinent art.
4. Considering objective evidence present in the application indicating obviousness or nonobviousness.
This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention.
Claims 17, 20, and 23 are rejected under 35 U.S.C. 103 as being unpatentable over Yaari (US PGPub 2017/0020568 A1) in view of George (US PGPub 2009/0099422 A1).
With respect to claim 17, Yaari discloses a medical device (10 in Fig. 1) for treating shoulder dystocia (abstract: “A surgical device for treating shoulder dystocia”) comprising:
a first arm (20) having a proximal portion (portion near 23) and a distal portion (portion near 32), the first arm (20) having a first curved surface (26);
a second arm (40) having a proximal portion (portion near 23) and a distal portion (portion near 52), the second arm (40) having a second curved surface (46);
a shoulder engagement section (60) positioned at least between the distal portion of the first and second arms (PP [0054]: “an engagement member 60 spanning the two arms 20, 40”) and connecting the first and second arms (20 and 40 are connected via 60, see Fig. 1), the engagement section (60) having an upper surface (66) and a lower surface (68 in Fig. 3A), the lower surface (68) having an atraumatic surface and configured to contact and press down on a baby (PP [0061]: “A portion of the lower (bottom) surface 68 (see FIG. 3A) (or the entire lower surface) can be textured or have some small atraumatic projections or other non-smooth surface to provide a good grip on the fetal shoulder for maneuverability”) to reposition the baby upon manipulation of the first and second arms (PP [0059]: “to apply a sufficient force against the baby's shoulder when a downward force is applied by manipulation of the arms 20, 40”), the upper surface (6) having a concave section forming a depression (see lateral depression in Fig. 1 created by curved sections 28 and 48) to accommodate the shoulder of the baby (see Figs. 13-16, this curved concave section accommodates the shoulder of the baby).
However, Yaari fails to disclose a lubricant bag, wherein the lubricant is contained in the lubricant bag, the lubricant bag is positioned about the engagement section such that the lubricant bag encapsulates the engagement section.
In the related field of speculums (abstract), which is related to the present invention as it is also a medical tool intended for insertion into the vagina of a patient, George teaches a lubricant bag containing lubricant which is positioned about a speculum such that the lubricant bag encapsulates the speculum (PP [0027]: “a package comprising a wrapper encapsulating at least part of a medical instrument such as a speculum, the package containing lubricant between the wrapper and the instrument to lubricate at least an encapsulated part of the instrument before removal of the wrapper”).
It would have been prima facie obvious for one of ordinary skill in the art before the effective filing date to have modified the Yaari device according to the teachings of George to include the lubricant bag as claimed. One of ordinary skill in the art would have been motivated to perform this modification in order to pre-lubricate the instrument while maintaining its sterility, to increase efficiency and safety as “the practitioner need not spend time smearing lubricant over the instrument with his fingers before use which might increase the chances of contamination” (PP [0029]). The modification as proposed would not alter the main operating principle of the Yaari device, but would simply and predictably provide a way to pre-lubricate the engagement section prior to use.
Regarding claim 20, Yaari as modified by George further discloses wherein the lubricant bag (PP [0027]: “a package comprising a wrapper encapsulating at least part of a medical instrument such as a speculum, the package containing lubricant between the wrapper and the instrument to lubricate at least an encapsulated part of the instrument before removal of the wrapper”) is a tear away bag openable to release the lubricant on the engagement section (PP [0033]: “the method suitably comprises manipulating the wrapper and/or the instrument to breach the barrier for distribution of the lubricant over the instrument”).
Regarding claim 23, Yaari as modified by George further discloses wherein the engagement section (60 in Fig. 1 of Yaari) is one of a spreadable material, balloon or cord (PP [0058]: “the engagement section 60 comprises a material in the form of a sheet or a cloth”, cloth is a spreadable material, PP [0060]: “when the arms are moved from the closed (unspread) to the open spread position, due to the shorter length distal end, the distal section of the engagement section will be more taut, and thus more rigid, than the proximal section to achieve the results described above”, see also Figs. 13-16 showing 60 spreading during use).
Double Patenting
The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969).
A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b).
The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13.
The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer.
Claims 17, 20, and 23 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 11-12 of U.S. Patent No. 10,321,935 B2 (hereinafter known as the ‘935 patent) in view of George (US PGPub 2009/0099422 A1).
With respect to claim 17, the ‘935 patent discloses a medical device for treating shoulder dystocia (claim 11, line 13) comprising:
a first arm having a proximal portion and a distal portion, the first arm having a first curved surface (claim 11, lines 16-20);
a second arm having a proximal portion and a distal portion, the second arm having a second curved surface (claim 11, lines 25-29);
a shoulder engagement section positioned at least between the distal portion of the first and second arms and connecting the first and second arms (claim 11, lines 35-37), the engagement section having an upper surface and a lower surface, the lower surface having an atraumatic surface and configured to contact and press down on a baby to reposition the baby upon manipulation of the first and second arms (claim 11, lines 41-49).
However, the ‘935 patent fails to disclose a lubricant bag, wherein the lubricant is contained in the lubricant bag, the lubricant bag is positioned about the engagement section such that the lubricant bag encapsulates the engagement section.
In the related field of speculums (abstract), which is related to the present invention as it is also a medical tool intended for insertion into the vagina of a patient, George teaches a lubricant bag containing lubricant which is positioned about a speculum such that the lubricant bag encapsulates the speculum (PP [0027]: “a package comprising a wrapper encapsulating at least part of a medical instrument such as a speculum, the package containing lubricant between the wrapper and the instrument to lubricate at least an encapsulated part of the instrument before removal of the wrapper”).
It would have been prima facie obvious for one of ordinary skill in the art before the effective filing date to have modified the device of the ‘935 patent according to the teachings of George to include the lubricant bag as claimed. One of ordinary skill in the art would have been motivated to perform this modification in order to pre-lubricate the instrument while maintaining its sterility, to increase efficiency and safety as “the practitioner need not spend time smearing lubricant over the instrument with his fingers before use which might increase the chances of contamination” (PP [0029]). The modification as proposed would not alter the main operating principle of the ‘935 patent, but would simply and predictably provide a way to pre-lubricate the engagement section prior to use.
Regarding claim 20, the ‘935 patent as modified by George further discloses wherein the lubricant bag (PP [0027]: “a package comprising a wrapper encapsulating at least part of a medical instrument such as a speculum, the package containing lubricant between the wrapper and the instrument to lubricate at least an encapsulated part of the instrument before removal of the wrapper”) is a tear away bag openable to release the lubricant on the engagement section (PP [0033]: “the method suitably comprises manipulating the wrapper and/or the instrument to breach the barrier for distribution of the lubricant over the instrument”).
Regarding claim 23, the ‘935 patent as modified by George further discloses wherein the engagement section (18 in Fig. 8 of Varma) is one of a spreadable material, balloon or cord (18 has balloon 12 on it).
Allowable Subject Matter
Claims 1-2 and 4-7 contain allowable subject matter.
Please note that the formal requirements of claim 4 must be addressed.
The following is an examiner’s statement of reasons for allowance: The subject matter of the independent claim 1 filed on 9/25/2026 could either not be found or was not suggested in the prior art of record.
With respect to claim 1, the prior art does not disclose or render obvious at the effective filing date of the invention: the feature of a spacer extending from the upper surface of the engagement section, the spacer including a first inflatable balloon and a second inflatable balloon spaced laterally apart from the first inflatable balloon such that the first inflatable balloon is closer to a first side edge than the second inflatable balloon, in combination with the other limitations of the independent claim.
The closest prior art is Vaari, which discloses each of the limitations as described above.
However, Vaari fails to disclose a spacer comprising the balloon features as claimed. Furthermore, the prior art of record does not suggest any motivation to modify the Vaari disclosure to arrive at these features.
Any comments considered necessary by applicant must be submitted no later than the payment of the issue fee and, to avoid processing delays, should preferably accompany the issue fee. Such submissions should be clearly labeled “Comments on Statement of Reasons for Allowance.”
Conclusion
Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a).
A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action.
Any inquiry concerning this communication or earlier communications from the examiner should be directed to Bridget E. Rabaglia whose telephone number is (571)272-2908. The examiner can normally be reached Monday - Thursday, 7am - 5pm.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jackie Ho can be reached at (571) 272-4696. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/BRIDGET E. RABAGLIA/Examiner, Art Unit 3771
/TAN-UYEN T HO/Supervisory Patent Examiner, Art Unit 3771